Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Clinical trial NCT05563220 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05563220
- Sponsor
- Stemline Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-24
- Primary completion
- 2026-12-27
- Enrollment
- 435
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.